Increase federal funding for programs engaged in vital research to combat rheumatic diseases.
Ensure long-term, viable patient access to telehealth services by resolving inter-state licensing issues and preserving reimbursement parity for virtual visits.
Stave off current cuts and work towards a long-term, sustainable solution to Medicare physician payment.
Support expansion of the rheumatology workforce by adequately funding Graduate Medical Education and permanently repealing the cap on Medicare funded training positions.
Increase transparency required for pharmacy benefit manager (PBM) operations and drug pricing mechanisms, including reporting requirements for rebates and drug price increases.
© Copyright 2024 RheumPAC - All Rights Reserved